Skip to content
Disclosery

Antara Capital LP

Follow

13F filer, CIK 1750183, New York, NY

Antara Capital LP reported $490,183 across 3 holdings for the quarter ended 2025-09-30, in a 13F-HR filed 2025-11-14.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001750183-25-000016

Period
2025-09-30
Reported value
$490K
Holdings
3
Top 10 weight
100%
New
2
Sold out
1

Largest buys vs the previous quarter

SecurityShares changeApprox. value
ASPIRE BIOPHARMA HLDGS INC …new+202,897$41.8K
ASBPWnew+207,693$6.21K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
CURRreduced-615,300-$1.03M
RZLVexited-131,250-$404K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2025

Share positions as resolved from 13F-HR 0001750183-25-000016, largest first. % of portfolio is the value over $490,183, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
CURRCURRENC GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: not reported; 2024Q2: not reported; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 878,500 shares; 2025Q3: 263,200 shares 263,200$442K90.21%-615,300Timeline
ASPIRE BIOPHARMA HLDGS INC …ASPIRE BIOPHARMA HLDGS INC COMQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: not reported; 2024Q2: not reported; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 202,897 shares 202,897$41.8K8.53%new
ASBPWASPIRE-LAKEWOOD HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: not reported; 2024Q2: not reported; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 207,693 shares 207,693$6.21K1.27%newTimeline

Sold out in Q3 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
RZLVREZOLVE AI PLC131,250$404Kshares

How Q3 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001750183-25-000016 base2025-11-14acceptance time not in the bulk data set